GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: Correlation with lung DNA adduct levels

European Journal of Cancer Prevention

Volumn 8, Issue 4, 1999, Pages 315-323

  Butkiewicz, D ^a   Cole, K J ^b   Phillips, D H ^b   Harris, C C ^c   Chorazy M ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

GST and CYP polymorphism; Lung cancer; PAH DNA adduct levels

Indexed keywords

DEBRISOQUINE 4 HYDROXYLASE; ETHOXYRESORUFIN DEETHYLASE; GLUTATHIONE TRANSFERASE; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; AGED; ARTICLE; CANCER RISK; DISEASE ASSOCIATION; DNA ADDUCT; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLAND; POLLUTION; PRIORITY JOURNAL; SMOKING;

EID: 0032841715     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199908000-00008     Document Type: Article

References (43)

1. Anttila S, Hirvonen A, Vainio H et al. (1993). Immunohistochemical localization of glutathione S-transferases in human lung. Cancer Res 53: 5643-8.
2. Bartsch H, Petruzzelli S, De Flora S et al. (1991). Carcinogen metabolism and DNA adducts in human lung tissues as affected by tobacco smoking or metabolic phenotype: a case-control study on lung cancer patients. Mutat Res 250: 103-14.
3. Bartsch H, Rojas K, Alexandrov K et al. (1995). Metabolic polymorphism affecting DNA binding and excretion of carcinogens in humans. Pharmacogenetics 5: S84-90.
4. Bouchardy C, Benhamou S, Dayer P (1996). The effect of tobacco on lung cancer risk depends on CYP2D6 activity. Cancer Res 56: 251-3.
5. Butkiewicz D, Grzybowska E, Hemminki K et al. (1998). Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1, CYP2D6 and GSTM1 genetic polymorphisms. Mutat Res 415: 97-108.
6. Caporaso N, DeBaun MR, Rothman N (1995). Lung cancer and CYP2D6 (the debrisoquine polymorphism): sources of heterogeneity in the proposed association. Pharmacogenetics 5: S129-S134.
7. Craighead JE (1995). Organ pathology of environmental and occupational disease. Airways and lung. In Pathology of Environmental and Occupational Disease (ed Craighead JE); Mosby-Year Book, Inc., St. Louis, pp. 455-90.
8. Crespi CL, Penman BM, Gelboin MV et al. (1991). A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis 12: 1197-201.
9. Dallinga JW, Pachen DMF, Wijnhoven SWP, et al. (1998). The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure. Cancer Epidemiol Biomarkers Prev 7: 571-7.
10. Grzybowska E, Hemminki K, Szeliga J et al. (1993). Seasonal variation of aromatic DNA adducts in human lymphocytes and granulocytes. Carcinogenesis 14: 2523-6.
11. Harrics LW, Stubbins MJ, Forman D et al. (1997). Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18: 641-4.
12. Harris CC (1989). Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair. Carcinogenesis 10: 1563-6.
13. Harris MJ, Coggan M, Langton L et al. (1998). Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics 8: 27-31.
14. Heim M., Meyer UA (1990). Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification. Lancet 336: 529-32.
15. Hemminki K, Grzybowska E, Chora̧ży M et al. (1990). Aromatic DNA adducts in white blood cells of coke workers. Int Arch Occup Environ Health 62: 467-70.
16. Hirvonen A, Husgafvel-Pursiainen K, Anttila S et al. (1993). The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 14: 1479-81.
17. Huang Z, Facso MJ, Spivack S et al. (1997). Comparisons of CYP2D messenger RNA splice variant profiles in human lung tumors and normal tissue. Cancer Res 57: 2589-92.
18. Kato S, Bowman ED, Harrington AM et al. (1995). Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J Natl Cancer Inst 87: 902-7.
19. Ketterer B, Harris JM, Talaska G et al. (1992). The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect 98: 87-94.
20. Kihara M, Kihara M., Noda K (1994) Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis 15: 415-18.
21. Kivisto KT, Griese K-U, Stuven T et al. (1997). Analysis of CYP2D6 expression in human lung: Implications for the association between CYP2D6 activity and susceptibility to cancer. Pharmacogenetics 7: 295-302.
22. Kiyohara C, Nakanishi Y, Inutsuka S et al. (1998). The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in the Japanese population. Pharmacogenetics 8: 315-23.
23. Legrand-Andreoletti M., Stucker I, Marez D et al, (1998). Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in Caucasians. Pharmacogenetics 8: 7-14.
24. Li D, Wang M, Cheng L et al. (1996). In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Cancer Res 56: 3638-41.
25. Pendzich J, Motykiewicz G, Michalska J et al. (1997). Sister chromatid exchanges and high-frequency cells in men environmentally and occupationally exposed to ambient air pollutants: an intergroup comparison with respect to seasonal changes and smoking habit. Mutat Res 381: 163-70.
26. Perera FP, Hemminki K, Grzybowska E et al. (1992). Molecular and genetic damage in humans from environmental pollution in Poland. Nature 360: 256-8.
27. Phillips DH (1996). DNA adducts in human tissues: biomarkers of exposure to carcinogens in tobacco smoke. Environ Health Perspect 104 (Suppl 3): 453-8.
28. Phillips DH, Schoket B, Hewer A et al. (1990). Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int J Cancer 46: 569-75.
29. Rannung A, Alexandrie A-K, Persson I et al. (1995). Genetic polymorphism of cytochromes P4501A1, 2D6 and 2E1: regulation and toxicological significance. JOEM 37: 25-36.
30. Raunio H, Husgafvel-Pursiainen K, Anttila S et al. (1995). Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - A review. Gene 159: 113-21.
31. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7: 1543-51.
32. Ryberg D, Hewer A, Phillips DH et al. (1994). Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 54: 5801-3.
33. Ryberg D, Skaug V, Hewer A et al. (1997). Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18: 1285-9.
34. Saarikoski ST, Husgafvel-Pursiainen K, Hirvonen A et al. (1998). Localization of CYP1A1 mRNA in human lung by in situ hybrizidation: comparison with immunohistochemical findings. Int J Cancer 77: 33-9.
35. Schoket B, Phillips DH, Kostic S et al. (1998). Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 Msp1 and GSTM1 genotypes in lung patients. Carcinogenesis 19: 841-6.
36. Seidegard J, Pero RW, Mirkowitz MM et al. (1990). Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to cancer: a follow-up study. Carcinogenesis 11: 33-6.
37. Shaw GL, Falk RT, Frame JN et al. (1998). Genetic polymorphism of CYP2D6 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 7: 215-19.
38. Shen MR, Jones IM, Mohrenweiser H (1998). Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58: 604-8.
39. Shields PG, Bowman ED, Harrington AM et al. (1993). Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res 53: 3486-92.
40. Vaury C, Laine R, Noguiez P et al. (1995). Human glutathione S-transferase M1 null genotype is associated with high inducibility of cytochrome P450 1A1 gene transcription. Cancer Res 55: 5520-3.
41. Watson MA, Stewart RK, Smith GB et al. (1998). Human glutathione S-transferase Pi polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19: 275-80.
42. Wei Q, Cheng L, Hong WK et al. (1996). Reduced DNA repair capacity in lung cancer patients. Cancer Res 56: 4103-7.
43. Zimniak P, Nanduri B, Pikula S et al. (1994). Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem 224: 893-9.